Impact of Urokinase Shortage on Empyema Management and Clinical Outcomes in Japan

Taiki Nishiba, Daisuke Yamasaki, Shiho Ito, Yusuke Asai, Masaki Tanabe

Open source

DOI
10.1016/j.jiac.2026.103086
Published
2026-09
Container
Journal of Infection and Chemotherapy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jiac.2026.103086,
  title = {Impact of Urokinase Shortage on Empyema Management and Clinical Outcomes in Japan},
  author = {Taiki Nishiba and Daisuke Yamasaki and Shiho Ito and Yusuke Asai and Masaki Tanabe},
  year = {2026},
  journal = {Journal of Infection and Chemotherapy},
  doi = {10.1016/j.jiac.2026.103086},
  url = {https://doi.org/10.1016/j.jiac.2026.103086}
}

RIS

TY  - JOUR
TI  - Impact of Urokinase Shortage on Empyema Management and Clinical Outcomes in Japan
AU  - Taiki Nishiba
AU  - Daisuke Yamasaki
AU  - Shiho Ito
AU  - Yusuke Asai
AU  - Masaki Tanabe
PY  - 2026
JO  - Journal of Infection and Chemotherapy
DO  - 10.1016/j.jiac.2026.103086
UR  - https://doi.org/10.1016/j.jiac.2026.103086
ER  - 

APA

Nishiba, T., Yamasaki, D., Ito, S., Asai, Y., & Tanabe, M. (2026). Impact of Urokinase Shortage on Empyema Management and Clinical Outcomes in Japan. Journal of Infection and Chemotherapy. https://doi.org/10.1016/j.jiac.2026.103086

Source records